This study examines the levels of oxidative damage in patients with retinopathy of prematurity (ROP).
Methods
Fifty patients were recruited with a birthweight below 1500 g or gestational age below 32 weeks. The cases were classified into those who developed ROP (n=25) and those without ROP (n=25). The authors obtained blood and urine samples from each infant, for measuring 8-hydroxy 2-deoxyguanosine (8-OHdG) and malondialdehyde (MDA) levels, at the time of the first examination at 4–6 postnatal weeks.
Results
A significant difference was observed in leukocyte and urine 8-OHdG levels in patients with ROP compared to those without ROP (p<0.001 for both). Similarly, a significant difference was observed in plasma and urine MDA levels in patients with ROP compared to those without ROP (p<0.001 for both). In addition, significant correlations were found between levels of 8-OHdG in leukocyte DNA and plasma MDA (r=0.859, p<0.001), and between levels of urine 8-OHdG excretion and urine MDA (r=0.563, p<0.001).
Conclusions
8-OHdG in leukocyte DNA and urine levels in premature infants can be useful as an indicator for ROP screening.
ChawlaD., AgarwalR., DeorariA.K., PaulV.K.Retinopathy of prematurity. Ind J Pediatr2008; 75: 73–6.
2.
FleckB.W., McIntoshN.Pathogenesis of retinopathy of prematurity and possible preventive strategies. Early Hum Dev2008; 84: 83–8.
3.
BossiE., KoernerF.Retinopathy of prematurity. Intens Care Med1995; 21: 241–6.
4.
MaheshwariR., KumarH., PaulV.K., SinghM., DeorariA.K., TiwariH.K.Incidence and risk factors of retinopathy of prematurity in a tertiary care newborn unit in New Delhi. Natl Med J India1996; 9: 211–4.
BonnefoyM., DraiJ., KostkaT.Antioxidants to slow aging, facts and perspectives. Presse Med2002; 31: 1174–84.
10.
IrshadM., ChaudhuriP.S.Oxidant-antioxidant system: role and significance in human body. Ind J Exp Biol2002; 40: 1233–9.
11.
LoftS., Fischer-NielsenA., JedingI.B., VistisenK., PoulsenH.E.8-Hydroxydeoxyguanosine as a urine biomarker of oxidative DNA damage. J Toxicol Environ Health1993; 40: 391–404.
12.
FloydR.A.The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis1990; 11: 1447–50.
KadiiskaM.B., GladenB.C., BairdD.D.Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?Free Radic Biol Med2005; 15: 698–710.
15.
American Academy of Pediatrics. Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics2001; 108: 809–11.
16.
AdeliK., OgbonnaG.Rapid purification of human DNA from whole blood for potential application in clinical chemistry laboratories. Clin Chem1990; 36: 261–4.
17.
MillerS.A., DykesD.D., PoleskyH.F.A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res1988; 11: 1215.
18.
KaurH., HalliwellB.Measurement of oxidized and methylated DNA bases by HPLC with electrochemical detection. Biochem J1996; 318: 21–3.
19.
ArmstrongD.Free radical and antioxidant protocols. Methods Mol Biol1998; 108: v–viii.
20.
KasaiH.Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res1997; 387: 147–63.
21.
TarngC., HuangT., WeiY.8-Hydroxy-2-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patient. Am J Kidney Dis2000; 36: 934–44.
22.
KhoschsorurG.A., Winklhofer-RoobB.M., RabP.H., AuerT., PengZ., SchaurR.J.Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatograph A2000; 52: 181–4.
23.
DaniC., CecchiA., BertiniG.Role of oxidative stress as physiopathologic factor in the preterm infant. Minerva Pediatr2004; 56: 381–94.
24.
KellyF.J.Free radical disorders of preterm infants. Br Med Bull1993; 49: 668–78.
ValenzuelaA.The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress. Life Sci1991; 48: 301–9.
27.
Cervantes-MunguiaR., Espinosa-LopezL., Gomez-ContrerasP., Hernandez-FloresG., Dominguez-RodriguezJ., Bravo-CuellarA.Retinopathy of prematurity and oxidative stress. An Pediatr2006; 64: 126–31.
FalcigliaH.S., JohnsonJ.R., SullivanJ.Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am J Perinatol2003; 20: 97–107.
30.
WeinbergerB., AnwarM., HenienS.Association of lipid peroxidation with antenatal betamethasone and oxygen radial disorders in preterm infants. Biol Neonate2004; 85: 121–7.
31.
KrapfenbauerK., BirnbacherR., VierhapperH., HerknerK., KampelD., LubecG.Glycoxidation, and protein and DNA oxidation in patients with diabetes mellitus. Clin Sci1998; 95: 331–7.
HolmesG.E., BernsteinC., BernsteinH.Oxidative and other DNA damages as the basis of aging: a review. Mutat Res1992; 275: 305–15.
34.
TrollW., WiesnerR.The role of oxygen radicals as a possible mechanism of tumor promotion. Annu Rev Pharmacol Toxicol1985; 25: 509–28.
35.
SlupphaugG., KavliB., KrokanH.E.The interacting pathways for prevention and repair of oxidative DNA damage. Mutat Res2003; 29: 231–51.
36.
CharissouA.M., Cossu-LeguilleC., VasseurP.Relationship between two oxidative stress biomarkers, malondialdehyde and 8-oxo-7, 8-dihydro-2′-deoxyguanosine, in the freshwater bivalve Unio tumidus. Sci Total Environ2004; 25: 109–22.
37.
MatsubasaT., UchinoT., KarashimaS.Oxidative stress in very low birth weight infants as measured by urine 8-OHdG. Free Radic Res2002; 36: 189–93.
38.
IzzottiA., SaccaS.C., CartigliaC., De FloraS.Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med2003; 114: 638–46.
39.
PanH.Z., ZhangH., ChangD., LiH., SuiH.The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol2008; 92: 548–51.
